Transcatheter Tricuspid Valve-in-Valve Replacement Using a J-Valve System for a Failed Tricuspid Bioprosthesis.

IF 0.6 Q4 CARDIAC & CARDIOVASCULAR SYSTEMS

Case Reports in Cardiology Pub Date : 2022-06-29 eCollection Date: 2022-01-01 DOI:10.1155/2022/7353522

Mingkui Zhang, Hui Xue, Lifu Miao, Xiujie Tang, Yanbin Shao

{"title":"Transcatheter Tricuspid Valve-in-Valve Replacement Using a J-Valve System for a Failed Tricuspid Bioprosthesis.","authors":"Mingkui Zhang, Hui Xue, Lifu Miao, Xiujie Tang, Yanbin Shao","doi":"10.1155/2022/7353522","DOIUrl":null,"url":null,"abstract":"Background: Redo operation for failed tricuspid bioprosthetic valves is associated with high morbidity and mortality. Transcatheter tricuspid valve-in-valve implantation has become an acceptable option for high-risk patients with a failed tricuspid bioprosthesis. We present a case of successful tricuspid valve-in-valve implantation using a J-valve in a failed tricuspid bioprosthesis position. Case Summary. A 48-year-old male, who had a failed tricuspid bioprosthesis, presented with right-side heart failure, right-to-left shunting at the atrial level, severe dyspnea, cyanosis, peripheral edema, hepatauxe, and ascites. After the interdisciplinary assessment, we successfully performed transcatheter tricuspid valve-in-valve implantation with the J-valve system. At 34-month postoperative follow-up, the patient had no symptoms of heart failure and the echocardiogram showed good valve position and well hemodynamic status.Conclusions: This case demonstrated that the J-valve system may be a new option for high-risk patients with a failed tricuspid bioprosthetic valve.","PeriodicalId":51760,"journal":{"name":"Case Reports in Cardiology","volume":" ","pages":"7353522"},"PeriodicalIF":0.6000,"publicationDate":"2022-06-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9259371/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Case Reports in Cardiology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1155/2022/7353522","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2022/1/1 0:00:00","PubModel":"eCollection","JCR":"Q4","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}

引用次数: 0

Abstract

Background: Redo operation for failed tricuspid bioprosthetic valves is associated with high morbidity and mortality. Transcatheter tricuspid valve-in-valve implantation has become an acceptable option for high-risk patients with a failed tricuspid bioprosthesis. We present a case of successful tricuspid valve-in-valve implantation using a J-valve in a failed tricuspid bioprosthesis position. Case Summary. A 48-year-old male, who had a failed tricuspid bioprosthesis, presented with right-side heart failure, right-to-left shunting at the atrial level, severe dyspnea, cyanosis, peripheral edema, hepatauxe, and ascites. After the interdisciplinary assessment, we successfully performed transcatheter tricuspid valve-in-valve implantation with the J-valve system. At 34-month postoperative follow-up, the patient had no symptoms of heart failure and the echocardiogram showed good valve position and well hemodynamic status.

Conclusions: This case demonstrated that the J-valve system may be a new option for high-risk patients with a failed tricuspid bioprosthetic valve.

Abstract Image

查看原文本刊更多论文

使用j型瓣膜系统进行经导管三尖瓣瓣内置换术治疗三尖瓣生物假体失败。

背景:三尖瓣生物假体瓣膜失效的再手术具有很高的发病率和死亡率。经导管三尖瓣瓣内植入术已成为三尖瓣生物假体失败的高危患者可接受的选择。我们提出一个案例成功的三尖瓣瓣内植入使用j型瓣膜在失败的三尖瓣生物假体位置。案例总结。48岁男性，三尖瓣生物假体失败，表现为右侧心力衰竭，心房水平右至左分流，严重呼吸困难，紫绀，外周水肿，肝纤维化和腹水。经过跨学科的评估，我们成功地使用j型瓣膜系统进行了经导管三尖瓣瓣内植入。术后随访34个月，患者无心衰症状，超声心动图显示瓣膜位置良好，血流动力学状态良好。结论:本病例表明j型瓣膜系统可能是三尖瓣生物假体瓣膜失败的高危患者的新选择。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Case Reports in Cardiology CARDIAC & CARDIOVASCULAR SYSTEMS-

自引率

0.00%

发文量

审稿时长

13 weeks

期刊介绍： Case Reports in Cardiology is a peer-reviewed, Open Access journal that publishes case reports and case series related to hypertension, arrhythmia, congestive heart failure, valvular heart disease, vascular disease, congenital heart disease and cardiomyopathy.